This concept is further supported by the observation that mice lacking iRhom2 are protected from bone resorption in a mouse model of hemophilia arthropathy, as are mice lacking the ADAM17 substrate TNFα or mice treated with the TNF antagonist Etanercept [41]. Here, RHBDF2 is linked to hemophilia.